Year |
Citation |
Score |
2018 |
Kaiser C, Rincon Pabon JP, Khowsathit J, Castaldi P, Kazmirski SL, Weis DD, Zhang AX, Karanicolas J. Modulating antibody structure and function through directed mutations and chemical rescue. Acs Synthetic Biology. PMID 29609459 DOI: 10.1021/Acssynbio.8B00124 |
0.409 |
|
2014 |
McEnaney PJ, Fitzgerald KJ, Zhang AX, Douglass EF, Shan W, Balog A, Kolesnikova MD, Spiegel DA. Chemically synthesized molecules with the targeting and effector functions of antibodies. Journal of the American Chemical Society. 136: 18034-43. PMID 25514603 DOI: 10.1021/Ja509513C |
0.698 |
|
2012 |
McEnaney PJ, Parker CG, Zhang AX, Spiegel DA. Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease. Acs Chemical Biology. 7: 1139-51. PMID 22758917 DOI: 10.1021/Cb300119G |
0.688 |
|
2012 |
Jakobsche CE, McEnaney PJ, Zhang AX, Spiegel DA. Reprogramming urokinase into an antibody-recruiting anticancer agent. Acs Chemical Biology. 7: 316-21. PMID 22098560 DOI: 10.1021/cb200374e |
0.753 |
|
2012 |
Chen WC, Zhang AX, Li SD. Limitations and niches of the active targeting approach for nanoparticle drug delivery European Journal of Nanomedicine. 4: 89-93. DOI: 10.1515/Ejnm-2012-0010 |
0.319 |
|
2012 |
Zhang AX, Hoimes CJ, Murelli RP, Saltzman WM, Spiegel DA. Abstract 4747: Redirecting the endogenous immune response against prostate cancer using an antibody-recruiting small molecule Cancer Research. 72: 4747-4747. DOI: 10.1158/1538-7445.Am2012-4747 |
0.757 |
|
2010 |
Zhang AX, Murelli RP, Barinka C, Michel J, Cocleaza A, Jorgensen WL, Lubkowski J, Spiegel DA. A remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules. Journal of the American Chemical Society. 132: 12711-6. PMID 20726553 DOI: 10.1021/Ja104591M |
0.751 |
|
2010 |
Hoimes CJ, Murelli RP, Kelly WK, Zhang AX, Cheng CJ, Fields RJ, Spiegel DA, Saltzman WM. Effect of vorinostat (V)-loaded PLGA nanoparticles (NP) surface modified with a PSMA ligand on prostate cancer (PC) cells. Journal of Clinical Oncology. 28: e13629-e13629. DOI: 10.1200/Jco.2010.28.15_Suppl.E13629 |
0.627 |
|
2009 |
Murelli RP, Zhang AX, Michel J, Jorgensen WL, Spiegel DA. Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancer. Journal of the American Chemical Society. 131: 17090-2. PMID 19888723 DOI: 10.1021/Ja906844E |
0.774 |
|
Show low-probability matches. |